Skip to main content
letter
. 2021 Apr 1;106(4):1182–1187. doi: 10.3324/haematol.2020.253450

Table 2.

Most common treatment-emergent adverse events and hematologic laboratory abnormalities while on treatment by patient age group and treatment arm in the safety population.

graphic file with name 1061182.tab2.jpg